Recombinant IFN-beta-1a from Ares-Serono reduces relapses, delays progression in MS Dec. 2, 1997 No Comments
Clinical efficacy of naltrexone demonstrated in patients with cholestatic pruritus Nov. 27, 1997 No Comments